US Stock MarketDetailed Quotes
HLVX HilleVax
- 1.830
- -0.060-3.17%
Close Nov 15 16:00 ET
- 1.830
- 0.0000.00%
Post 16:22 ET
91.15MMarket Cap-592P/E (TTM)
1.940High1.830Low253.73KVolume1.940Open1.890Pre Close474.46KTurnover0.85%Turnover RatioLossP/E (Static)49.81MShares20.22052wk High0.49P/B54.76MFloat Cap1.55052wk Low--Dividend TTM29.92MShs Float24.420Historical High--Div YieldTTM5.82%Amplitude1.550Historical Low1.869Avg Price1Lot Size
HilleVax Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -3.79%-27.82M | -32.84%-29.78M | -106.86%-33M | -40.00%-86.78M | -16.68%-21.61M | -37.14%-26.81M | -69.70%-22.42M | -48.89%-15.95M | -749.75%-61.99M | -341.51%-18.52M |
| Net income from continuing operations | 18.83%-25.82M | -45.75%-40.67M | -74.16%-46.83M | 22.68%-123.57M | -74.44%-36.96M | -89.32%-31.82M | 48.26%-27.9M | 60.39%-26.89M | -56.05%-159.81M | 43.24%-21.19M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 68.33%43.62M | --0 |
| Depreciation and amortization | 28.94%842K | 90.19%795K | 95.84%707K | 87.80%2.16M | 132.05%724K | 61.23%653K | 0.00%418K | 2,676.92%361K | 38,166.67%1.15M | 15,500.00%312K |
| Other non cash items | -403.38%-986K | 41.67%340K | 7,017.27%15.66M | -97.95%1.12M | 121.48%330K | 153.91%325K | -99.30%240K | -98.88%220K | -6.06%54.35M | -99.21%149K |
| Change In working capital | -661.34%-7.62M | -239.38%-3.04M | -183.42%-6.43M | 631.73%22.84M | 1,218.43%11.59M | 132.97%1.36M | 341.59%2.18M | 5,173.68%7.71M | -138.10%-4.3M | -90.18%879K |
| -Change in prepaid assets | -283.33%-374K | 164.94%869K | -161.21%-1.16M | 136.28%4.02M | 150.96%1.59M | 106.37%204K | 107.44%328K | 659.00%1.9M | -9,443.97%-11.07M | -3,291.30%-3.12M |
| -Change in payables and accrued expense | -954.18%-6.81M | -550.65%-3.47M | -217.49%-5.18M | 155.39%14.48M | 179.44%9.95M | 48.77%-646K | -75.75%770K | 2,148.98%4.41M | -50.22%5.67M | -60.62%3.56M |
| -Change in other working capital | -124.39%-439K | -140.79%-443K | -106.67%-94K | 293.39%4.34M | -89.04%48K | 424.78%1.8M | --1.09M | --1.41M | --1.1M | --438K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -3.79%-27.82M | -32.84%-29.78M | -106.86%-33M | -40.00%-86.78M | -16.68%-21.61M | -37.14%-26.81M | -69.70%-22.42M | -48.89%-15.95M | -749.75%-61.99M | -341.51%-18.52M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 262.44%50.64M | 96.14%-3.47M | -1,831.73%-57.66M | -1,352.84%-94.64M | 869.63%29.47M | -16,750.81%-31.17M | -89.95M | -19.40%-2.99M | -131.98%-6.51M | -12,663.33%-3.83M |
| Net PPE purchase and sale | 90.30%-212K | 99.03%-47K | 94.87%-153K | -167.76%-10.75M | 80.73%-738K | -1,081.62%-2.19M | ---4.84M | ---2.99M | -8,820.00%-4.01M | -12,663.33%-3.83M |
| Net intangibles purchase and sale | ---1.5M | --0 | ---13.83M | --0 | --0 | --0 | --0 | --0 | 9.52%-2.5M | --0 |
| Net investment purchase and sale | 280.60%52.35M | 95.98%-3.42M | ---43.68M | ---83.89M | --30.21M | ---28.99M | ---85.11M | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 262.44%50.64M | 96.14%-3.47M | -1,831.73%-57.66M | -1,352.84%-94.64M | 869.63%29.47M | -16,750.81%-31.17M | ---89.95M | -19.40%-2.99M | -131.98%-6.51M | -12,663.33%-3.83M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -125.43%-27.5M | -93.97%615K | 18,727.50%15.06M | -47.24%118.7M | -96.77%313K | 3,933.58%108.11M | -95.33%10.2M | 180.81%80K | 67.62%224.97M | 1,327.76%9.69M |
| Net issuance payments of debt | ---27.5M | ---- | ---- | -33.17%9.8M | --0 | --0 | ---- | ---- | -89.14%14.67M | --10M |
| Net common stock issuance | -100.73%-790K | 54.52%615K | 18,727.50%15.06M | -52.65%108.9M | --798K | --107.62M | --398K | --80K | 23,000,500.00%230.01M | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2,397.08%-19.7M | ---313K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -125.43%-27.5M | -93.97%615K | 18,727.50%15.06M | -47.24%118.7M | -96.77%313K | 3,933.58%108.11M | -95.33%10.2M | 180.81%80K | 67.62%224.97M | 1,327.76%9.69M |
| Net cash flow | ||||||||||
| Beginning cash position | -31.21%110.08M | -45.57%142.71M | -22.32%218.31M | 125.61%281.03M | -28.45%210.13M | -49.40%160.01M | 135.66%262.17M | 125.61%281.03M | 27,157.33%124.57M | 126.65%293.69M |
| Current changes in cash | -109.34%-4.68M | 68.06%-32.63M | -300.88%-75.6M | -140.09%-62.72M | 164.59%8.18M | 322.27%50.13M | -149.84%-102.17M | -41.65%-18.86M | 26.07%156.47M | -152.52%-12.66M |
| End cash Position | -49.84%105.4M | -31.21%110.08M | -45.57%142.71M | -22.32%218.31M | -22.32%218.31M | -28.45%210.13M | -49.40%160.01M | 135.66%262.17M | 125.61%281.03M | 125.61%281.03M |
| Free cash flow | -1.87%-29.53M | -9.43%-29.83M | -148.06%-46.98M | -42.37%-97.53M | 0.01%-22.34M | -46.93%-28.99M | -106.33%-27.26M | -43.31%-18.94M | -578.05%-68.5M | -429.02%-22.35M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data